Module 5 Postanalytical Phase of Laboratory Testing.

Slides:



Advertisements
Similar presentations
CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
Advertisements

Conducting Patient Safety Rounds with Staff. First Steps Set the stage –Unit and Hospital Leadership Support –Identify a “champion(s)” for each unit where.
Analytic Phase of Laboratory Testing
Nursing and Lab partnering to perform
A Quality Improvement and Patient Safety project for Kaleida Health April 2010.
MLAB 2401: C LINICAL C HEMISTRY K ERI B ROPHY -M ARTINEZ Point of Care Testing 1.
Directorate of Laboratory Medicine1 Sample handling Malcolm Dunlop Directorate Quality Manager.
Disclosure/Communication of Laboratory Errors Raouf E Nakhleh, MD Mayo Clinic Florida.
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Drug Utilization Review (DUR)
1 Assessment: Audits. Assessment: Audits - Module 9 2 Learning Objectives At the end of this activity, you will be able to: Develop a process to prepare.
The Diagnostic Testing Process
Introduction to the Principles of Laboratory Medicine.
Quality Assurance Programs for the Emergency Department Jim Holliman, M.D., F.A.C.E.P. Professor of Military and Emergency Medicine Uniformed Services.
Introduction to Laboratory Testing NURS B20. The Nurse’s Role in Diagnostic Testing Nursing responsibilities extend to all 3 phases of the testing process-
Quality Improvement Prepeared By Dr: Manal Moussa.
1 Quality Control Procedures During Autotransfusion AmSECT New Advances in Blood Management Meeting Seattle, Washington September 8, 2011John Rivera.
Unit #7 - Basic Quality Control for the Clinical Laboratory
For Medication Certified Staff Members Only.   Governs how we give medications in a school setting  States that each parish will develop, follow and.
Chapter 17 Nursing Diagnosis
Introduction to the Principles of Laboratory Medicine Photos by Theresa Kristopaitis, MD.
2015 National Patient Safety Goals and the Older Adult Julie Pope Nurs 4292 Spring I Columbus State University.
Recommended by the Sentinel Event Alert Advisory Group NATIONAL PATIENT SAFETY GOALS FY 2009.
Performance Improvement in Microbiology Laboratory
Delegation of Care & Specialized Health Services for Health Assistants Janie Lee Hall, School Health Advocate, NW Region Office of School & Adolescent.
MIXING STUDIES General Approach of Haemostasis
National Patient Safety Goals 2011
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
Clinical Pharmacy Part 2
Copyright © 2008 Delmar Learning. All rights reserved. Unit 8 Observation, Reporting, and Documentation.
Quality Assurance Positive Outcomes for Negative Events Quality Assurance monitors operational systems:Pre-analytical AnalyticalPost-analytical Tools Used:
1 Vulnerable Time During Patient Transitions Terrence O’Malley, MD Medical Director, Non-Acute Care Services Partners HealthCare
1 Vulnerable Time During Patient Transitions Terrence O’Malley, MD Medical Director, Non-Acute Care Services Partners HealthCare
4 WELCOME. 4 Two Significant Stats 70 % 40%
Step What happens?. Who is responsible? Procedures needed?
Basic Nursing: Foundations of Skills & Concepts Chapter 9
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
CORE LABORATORY QA PROGRAM. Why have a QA Program? JCAHO Standard PI.1.10: The organization collects data to monitor its performance. Standard PI.2.10:
ESRD Network 6 5 Diamond Patient Safety Program Medication Reconciliation 2009.
© Copyright, The Joint Commission 2015 National Patient Safety Goals.
VERIFICATION OF BLOOD COLLECTION SYSTEM GIAN LUCA SALVAGNO, MD, PhD University of Verona, Italy.
Quality control & Statistics. Definition: it is the science of gathering, analyzing, interpreting and representing data. Example: introduction a new test.
Texas Pediatric Society Electronic Poster Contest A study of clinical-laboratory interface involving critical laboratory values: diagnostic errors in physician’s.
1 Patient Safety In China Gao Xinqiang 23 June 2014.
Department of Patient RelationsMeasuring to Achieve Patient Safety Safety Observer’s Orientation.
CBER Common Problems on Source Plasma Inspections Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Module Three: Identifying your Patient in SIS. Introduction – Search for 1 st T Specimen The Search for 1 st T Specimen screen is used to access your.
National Patient Safety Goals 2008 T he University of Toledo Medical Center Toledo, Ohio.
Pre- analytic Analytic Post- analytic  S pecimen collection  Specimen transport  Specimen quality  Result accuracy  Clerical.
The Implementation of Medication Reconciliation in PAC Enhancing Patient Safety The Implementation of Medication Reconciliation in PAC Enhancing Patient.
TLCTLC TLCTLC LTCLTC LTCLTC Delaware Valley Geriatric Education Center When Wrong Things Happen with Medications: Risk and Prevention by Donna Miller,
Module Five: Viewing Results in SIS. Introduction – Viewing Results Accurately communicating case interpretation to patients is one of the most important.
11 WAYS TO DECREASE DOOR TO NEEDLE TIME YOU CAN DO IT FASTER Jeff Nickel, MD FACEP ED Medical Director Parkview Regional Medical Center.
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics Roles Senior clinician Coordinate team and allocate roles Determine volume and type.
Monitoring Process for Pregnancy Category D or X Medications in Women of Childbearing Age Jody L. Lounsbery, PharmD, BCPS, Barbara Leone, MD University.
PATIENT & FAMILY RIGHTS AT DOHMS. Fully understand and practice all your rights. You will receive a written copy of these rights from the Reception, Registration.
© 2016 Cengage Learning ®. All Rights Reserved. May not be scanned, copied or duplicated, or posted to a publicly accessible website, in whole or in part.
Spotlight Case Watch the Warfarin!. 2 Source and Credits This presentation is based on the July 2011 AHRQ WebM&M Spotlight Case –See the full article.
Collaborative Pilot Project: Connecting EMRs with the IL PMP to Improve Medication Safety IL Prescription Monitoring Program IHA’s Institute for Innovations.
Veterinary Practice Laboratory Unit 1 Chapter 5 Quality Control and Record Keeping Copyright © 2015 by Mosby, an imprint of Elsevier Inc. All rights reserved.
Antibiotics: handle with care!
Unit #6 - Basic Quality Control for the Clinical Laboratory
Warfarin pretest Joshua Steinberg MD.
General Approach of Haemostasis
Medication Reconciliation ROP Compliance
General Approach in Investigation of Hemostasis
This is an archived document.
Point-of-Care vs Laboratory INR Testing to Optimize Anticoagulation Management.
Using Your EMR for More than Just Documenting
Postanalytical Phase of Laboratory Testing
Presentation transcript:

Module 5 Postanalytical Phase of Laboratory Testing

Once an accurate test result is obtained the lab must O Report the result in a timely manner by: O Using an electronic process allowing for acceptable results to be transmitted electronically via an ‘interface’ between the analyzer and lab information system(LIS) and then via another ‘interface’ between the LIS and the electronic medical record (EMR) or…. O Transcribing accurately the results to a paper or written medical record O The vast majority of results are transmitted by the first mechanism Photo by Theresa Kristopaitis, MD

Case Scenario 1 O A 68-year old woman with atrial fibrillation chronically anticoagulated with warfarin presents for her monthly INR blood draw. She relates to the nurses that her husband died unexpectedly 3 weeks ago and she has had a very poor appetite since. Photo by Theresa Kristopaitis, MD

Case Scenario 1 Result Component Value Flag Reference Range PROTHROMBIN TIME 68.6 H SEC INR RATIO 5.3 H Comment: SUGGESTED THERAPEUTIC RANGE FOR CONTROL OF ORAL ANTICOAGULANT THERAPY INR FOR DVT/PE, TISSUE VALVE, ATRIAL FIB, MI-STROKE PREVENT INR FOR MECHANICAL VALVE

Case Scenario 1 Per the laboratory guidelines, the INR result is considered a “critical result”. What is the next appropriate step taken by the laboratory technologist? A. Call the patient with the abnormal test result B. Communicate the INR result directly to the ordering physician or their designate C. Notify the coagulation laboratory director of the test result D. Order a STAT re-draw of the patient sample and notify the patient E. Rush the written result report into the medical record

“Critical Results” O “Critical results” of tests fall significantly outside the normal range, may indicate a life threatening situation, and may require immediate clinical action O Values are decided upon in collaboration with institution laboratory directors and physician leadership O The objective is to provide the responsible licensed caregiver with these results within an established time frame so that the patient can be promptly treated O The reporting of critical results in a timely basis is a 2013 JCAHO National Hospital Patient Safety Goal

“Critical Results” O Current regulations require that the person receiving the report of the critical result be asked to read back the results to the lab staff member to ensure correct information was communicated O This must be documented in the medical record Photo Theresa Kristopaitis, MD

Other Examples of Clinical Laboratory Critical Results Less than Greater than Hemoglobin O Ages 1 mo-adult 7.0 g/dL 19.0 g/dL O Ages 1 day – 1 mo 7.0 g/dL 20.5 g/dL O Ages 0 -1 day7.0 g/dL 24.0 g/dL Ionized Calcium (ICAL)0.85 mmol/L 1.50 mmol/L (Ages months) 0.95 mmol/L 1.65 mmol/L Lithium (LI) 2.0 mmol/L (Toxic Range) Partial Thromboplastin Time (PTT)100 seconds Potassium (K) (serum or plasma) 2.8 mmol/L6.1 mmol/L Potassium (K) (whole blood) 2.5 mmol/L 6.5 mmol/L Critical Results in Microbiology The physician or designate is notified for: Positive CSF smears

It Starts and Ends with the Patient O Remember that the laboratory testing process begins and ends with patient care O All laboratory tests MUST be interpreted in light of the clinical situation O Although lab testing may yield unexpected results that are critical in guiding further patient evaluation and management, clinicians must be vigilant for the possibility of spurious results from improper specimen collection, mislabeled specimens, clerical errors and other preanalytic, analytic and postanalytic ‘misadventures.’

Laboratory Staff are Members of the Healthcare Team! O Clinicians should ALWAYS feel free to contact lab directors and/or clinical laboratory staff with questions about any lab test: O Interpretation of results O Assurance of quality of a test O Discussion of potential sources of error or variables to be considered in test interpretation O Determination of need for a specialized test

O Proceed to Module 6 “Normal Values”: How are Normal Reference Ranges Established?